Panenteric surveillance of post allogeneic hematopoietic stem cell transplantat patients by using colon capsule endoscopy

Panenteric surveillance of post allogeneic hematopoietic stem cell transplantat patients by using colon capsule endoscopy - Panenteric surveillance of post allogeneic hematopoietic stem cell transplantat patients by using colon capsule endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022107

Enrollment

Registered

2016-04-27

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post allogenic hematopoietic stem cell transplantation

Interventions

Performing colon capsule endoscopy in the 21-28 day after post allogenic hematopoietic stem cell transplantation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are scheduled for allogenic hematopoietic stem cell transplantation.

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Having medical equipment in the body(e.g. pacemaker) 3.Intestinal obstruction. 4. Suspected or known Chrohn's disease. 5.Known to invasive gastrointestinal disease associate with Blood disease. 6. Contraindication for endoscopy 7. Patients who have morphine refractory diarrhea 8. Allergy of following medicine 8-1. Mosapride 8-2. Dimethicone 8-3. PEG with ascorvic acid

Design outcomes

Primary

Measure	Time frame
Sensitivity of colon capsule endoscopy as compared to the conventional endoscopy and histopathology.	—

Secondary

Measure	Time frame
Correlation between colon capsule endoscopic findings and Acute GVHD clinical grades.	—

Countries

Japan

Contacts

Public ContactNaoki Hosoe

Keio University Hospital Center for Diagnostic and Therapeutic Endoscopy

nhosoe@z5.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026